Abstract Cupiennin 1a, a cytolytic peptide isolated from the venom of the spider Cupiennius salei, exhibits broad membranolytic activity towards bacteria, trypanosomes, and plasmodia, as well as human blood and cancer cells. In analysing the cytolytic activity of synthesised all-D-and all-L-cupiennin 1a towards pro-and eukaryotic cells, a stereospecific mode of membrane destruction could be excluded. The importance of negatively charged sialic acids on the outer leaflet of erythrocytes for the binding and haemolytic activity of L-cupiennin 1a was demonstrated. Reducing the overall negative charges of erythrocytes by partially removing their sialic acids or by protecting them with tri-or pentalysine results in reduced haemolytic activity of the peptide.
Introduction
The hunting success of the Central American spider Cupiennius salei (Ctenidae) strongly depends on the power of its chelicerae and the paralysing/killing effect of its venom. The venom is characterised by proteins, low molecular mass compounds and peptides. Beside neurotoxins and enhancer peptides, about one-third of the venom consists of small cysteine-free peptides, the cupiennins (Kuhn-Nentwig et al. 2002b) which are also named M-ctenitoxin-Cs1a-1d according to a newly proposed toxin nomenclature (ArachnoServer spider toxin database http://www.arachnoserver.org/). These a-helical peptides are highly cationic and exhibit strong cytolytic activities towards different prokaryotic cells and human erythrocytes (Kuhn-Nentwig et al. 2002b) . A dual role is proposed for cupiennins in that: (1) due to their cytolytic activity they synergistically enhance the activity of neurotoxins and other venom peptides Wullschleger et al. 2004 Wullschleger et al. , 2005 and (2) they protect chelicerae and venom glands against microbial infections (Kuhn-Nentwig 2003) . The best investigated cytolytic peptide, cupiennin 1a, is characterised by a helix-hinge-helix structure (Pukala et al. 2007a ), comparable to the structure of latarcin 2a (M-zodatoxin-Lt2a), a cytolytic peptide isolated from the venom of the central Asian spider Lachesana tarabaevi (Zodariidae) (Kozlov et al. 2006) . As a linear cationic peptide, cupiennin 1a adopts a-helical conformation in the presence of negatively charged membranes and is attracted to the membrane by electrostatic interactions.
31 P solid-state nuclear magnetic resonance (NMR) spectroscopy of different phospholipid bilayers with cupiennin 1a (Cu1a) points to a possible toroidal pore formation as the mechanistic basis of its antimicrobial effect (Pukala et al. 2007a) . Remarkably, Cu1a exhibits a second, non-membranolytic activity: in the submicromolar range, the peptide inhibits the formation of nitric oxide by neuronal nitric oxide synthase through complexation with the regulatory protein Ca 2? calmodulin (Pukala et al. 2007b) . This indicates that the targets of Cu1a in a spider's prey are not only the cell membranes, but also cellular enzymes. Their inhibition, in combination with pore formation by Cu1a, together with the action of other venom compounds leads to the rapid destruction of vitally important systems.
Investigations concerning the antimicrobial activity of all-D and all-L enantiomers of several host defence peptides revealed that all-D enantiomers have the same or even improved antimicrobial activity due to slower enzymatic inactivation than natural all-L enantiomers (Bessalle et al. 1990; Jung et al. 2007; Kitani et al. 2009; Li et al. 2000; Mäntylä et al. 2005; McGwire et al. 2003; Thevissen et al. 2005; Vunnam et al. 1998; Wade et al. 1990; , indicating a chirally independent mechanism of membrane disruption. Nevertheless, a dual mode of action is reported for a proline-rich antibacterial peptide, cathelicidin Bac7: a stereospecificity-dependent uptake and binding to an intracellular target at near-MIC concentrations and a non-stereoselective membrane disruption at higher concentrations (Podda et al. 2006) .
To exclude a stereospecific cytolytic effect of all-Dcupiennin 1a (D-Cu1a) and all-L-cupiennin 1a (L-Cu1a), we performed bioassays with bacteria, trypanosomes, human erythrocytes and Drosophila melanogaster. Since we did not detect any stereospecificity, we tested the cytolytic activity of only L-Cu1a towards Plasmodium falciparum and different human blood cells as well as leukemic and tumour cells. To explore the membranespecific mode of action of L-Cu1a, we also analysed the involvement of sialic acids in the haemolytic activity of L-Cu1a by protection or partial removal of these groups.
Materials and methods

Peptides
C-terminal amidated all-L-(L-Cu1a) and all-D-cupiennin 1a (D-Cu1a) were synthesised by BACHEM AG (Bubendorf, Switzerland). Trilysine, pentalysine and neuraminidase were purchased from Sigma-Aldrich (Buchs, Switzerland).
Antimicrobial assays
Escherichia coli ATCC 25 922 and Staphylococcus aureus ATCC 29213 were cultured in Mueller-Hinton broth. The bactericidal activity of the peptides was determined using a microtiter broth dilution assay (Wu and Hancock 1999) . The bacterial inoculum prepared from mid log phase cultures was diluted to a final concentration of *3.7 9 10 5 cfu/ml. Twofold dilution of peptides (L-Cu1a or D-Cu1a: 0.04-2.5 lM), non-treated growth control and a sterility control were tested sixfold as described earlier (Kuhn-Nentwig et al. 2002b) . Cell growth was estimated by monitoring the optical density at 630 nm and the resulting colony forming units were counted after 18 h of incubation at 37°C.
Trypanosoma brucei brucei MiTat1.2(221) were cultured in HMI-9 medium (Hesse et al. 1995) supplemented with 10% (v/v) FCS at 37°C in a 5% CO 2 atmosphere in 25 cm 2 tissue culture flasks. For toxin assays, cells were seeded into 96-well microtiter plates (100 ll/well, 1 9 10 4 cells/well). Serial peptide dilutions were added in triplicate (5 ll/well), and plates were incubated for 68-72 h at 37°C in a 5% CO 2 atmosphere. At the end of this period, 10 ll/well of resazurin (Sigma R7017; 0.5 mM in PBS) were added, and incubation was continued for an additional 2 h before fluorescence was determined (Räz et al. 1997 ) (excitation at 536 nm, emission at 588 nm).
In vitro assays for detection of antiprotozoal activity against Plasmodium falciparum (K1 strain resistant to chloroquine and pyrimethamine), Trypanosoma brucei rhodesiense (bloodstream forms), and Trypanosoma cruzi (intracellular amastigotes in L-6 rat skeletal myoblasts) were carried out in duplicate as reported previously (Ganapaty et al. 2006 ).
Cytotoxicity against L-6 cells
Cytotoxicity assay was performed in a 96-well microtiter plate in duplicate, each well containing 100 ll of RPMI 1640 medium supplemented with 1% L-glutamine (200 mM) and 10% foetal bovine serum, and 4 9 10 4 L-6 cells (a primary cell line derived from rat skeletal myoblasts). Serial L-Cu1a dilutions of seven threefold dilution steps covering a range from 90 to 0.123 lg/ml were prepared. After 72 h of incubation the plate was inspected under an inverted microscope to assure growth of the controls and sterile conditions. Subsequently, Alamar blue (10 ll) was added to each well and the plate incubated for another 2 h. The plates were then read with a Spectramax Gemini XS microplate fluorometer using an excitation wavelength of 536 nm and an emission wavelength of 588 nm (Räz et al. 1997) . Data were analysed using the microplate reader software Softmax Pro.
Insecticidal activity
Drosophila melanogaster were used to determine the insecticidal activity of the peptides. Eleven (L-Cu1a) and nine (D-Cu1a) different peptide concentrations between 1.5 and 29.3 pmol/mg fly (injected in a total volume of 0.05 ll of insect ringer) were tested on each of 20 flies and 20 flies were used as controls (0.05 ll of insect ringer only). Calculations of the lethal doses LD 50 (50% of the test flies died of intoxication 24 h post-injection) were performed as described elsewhere (Kuhn-Nentwig et al. 2000) .
Haemolytic activity
Peptide (L-Cu1a or D-Cu1a; 0.2-50 lM) induced haemolysis (incubation for 1 h at 37°C) was determined using fresh human red blood cells (2.4 9 10 8 cells/ml). Release of haemoglobin was monitored by changes in the absorbance at 541 nm (Jasco V-550, Japan). The positive control (100% haemolysis) was human erythrocytes in distilled water and the negative control (0% haemolysis) was human erythrocytes in phosphate-buffered saline as described in (Kuhn-Nentwig et al. 2002b) .
Protection experiments with tri-or penta-lysine
The haemolytic activity of 2.5 lM L-Cu1a was determined in the presence of increasing concentrations of trilysine or pentalysine. Erythrocytes (1.7 9 10 8 cells/ml) were preincubated for 10 min with trilysine (0.1-1 mM) or pentalysine (0.1-0.5 mM) at 25°C in 230 ll of PBS A (5 mM NaH 2 PO 4 9 H 2 O, 150 mM NaCl, pH 7.2). After adding 20 ll L-Cu1a, the erythrocytes were further incubated for 1 h at 37°C. The percentage of haemolysis was calculated as mentioned above.
Sialic acid depletion of erythrocytes
Human erythrocytes (20% haematocrit) were incubated with neuraminidase (Clostridium perfringens Type V, Sigma, 1-80 lg/ml) in PBS B (5 mM NaH 2 PO 4 9 H 2 O, 150 mM NaCl, 0.5 mM CaCl 2 9 2H 2 O, pH 7.2) for 1 h at 37°C. Determination of released sialic acids was done with the resorcinol/FeCl 3 method as described (Reuter and Schauer 1994 ) and a calibration curve was generated with sialic acid (N-acetylneuraminic acid, Type IV-S, Sigma) in a concentration range from 1 to 10 lg. Then, sialic acid depleted erythrocytes were washed four times with PBS A and diluted to 1.6 9 10 7 cells/ml. Erythrocytes were incubated with L-Cu1a (5.4 lM) for 1 h at 37°C and haemolysis was determined as described above.
LDH assay of human blood and cancer cells Erythrocytes, lymphocytes, and granulocytes were obtained from anticoagulated human blood from healthy volunteers as described earlier (Willems et al. 2002) . Various human cancer cells were obtained from the Rega Institute (K.U. Leuven, Belgium). Human tumour cells were cultured in RPMI-1640 medium, supplemented with 10% foetal calf serum, 2 mM glutamine, penicillin (100 U/ ml) and streptomycin (100 lg/ml) at 37°C, 5% CO 2 and 95% relative humidity. Cells were washed with phosphatebuffered saline (PBS) buffer and directly used except for HEK, HEK/SV40 and HeLa cells, which were harvested after trypsinization and then washed with PBS buffer.
For the lactate dehydrogenase assay (LDH assay), human granulocytes, lymphocytes, erythrocytes and diverse cancer cells (4-6 9 10 6 cells/ml) were incubated with different concentrations of L-Cu1a in 300 ll of PBS buffer for 20 min at 37°C. Afterwards, the samples were centrifuged and 100 ll supernatant was used in the LDH assay with pyruvate as substrate and NADH as coenzyme, and measured at 340 nm as described (Bergmeyer and Bernt 1974) .
Granulocytes and activation assays
Inhibition of superoxide production by NADPH oxidase activity was measured as follows. Granulocytes were diluted to a final concentration of 2 9 10 5 /ml. Lyophilized L-Cu1a (60 lg/50 ll) was dissolved in water and added to 300 ll of granulocyte suspension to obtain a final concentration of 2 9 10 -7 and 5 9 10 -7 M of L-Cu1a. After incubation for 1 h at 37°C, 50 ll lucigenin (0.5 mg/ml) was added and the background chemiluminescence was measured. Then 50 ll phorbol myristate acetate (PMA, 1 lg/ml) was added and superoxide production was measured for 10-15 min using a Biolumat 9505 (Berthold, Germany) apparatus. Peak luminescence values were compared and inhibition was calculated as a percentage of superoxide production produced by PMA in control samples (no cytolytic peptide present).
The chemotaxis assay was performed using 24-well plates (Transwell-Costar, pore size 3 mm). Upper wells (200 ml) contained granulocytes (±10 6 /ml), and lower wells (400 ll) L-Cu1a or control. At the end of the 1 h experiment (at 37°C) a cell sample was taken from both compartments and counted. The migration ratio was calculated. Both negative (no L-Cu1a) and positive controls (formylated tripeptide fMLP, 3 9 10 -8 M) were included and results expressed in relation to the value for fMLP (set = 100%).
Cu1a: non-stereospecific cytolytic activity 71
The human cells (leucocytes and erythrocytes) were obtained after informed consent according to the ethical guidelines of the K.U. Leuven, Belgium, and the guidelines for researcher of the University Bern, Switzerland.
For statistics, the peptide concentrations at which 50% haemolysis, cell growth inhibition or inhibition of cell viability was observed (EC 50 ; IC 50 ) were derived using sigmoidal curve fitting software (GraphPad Prism 4.0, Graph Pad Software).
Results and discussion
Cytolytic activity of D-Cu1a and L-Cu1a enantiomers on trypanosomes, bacteria, human erythrocytes and insects
The cytolytic activity of different concentrations of D-Cu1a and L-Cu1a on diverse membrane types is mostly within a comparable submicromolar range (Fig. 1) . The trypanocidal activity of the enantiomers exhibits no major differences, with an IC 50 of 0.136 lM for D-Cu1a and 0.120 lM for L-Cu1a (Fig. 1a) . The microscopically observed minimal inhibition concentrations (MIC) for both peptides were estimated at 0.328 lM for T. brucei 221. In addition, no differences are visible in their haemolytic activity (Fig. 1b) , with an EC 50 of 3.32 lM (D-Cu1a) and 3.10 lM (L-Cu1a). However, the bactericidal activity of DCu1a (IC 50 0.375 lM) towards E. coli was twofold higher than determined for the L-variant (IC 50 0.774 lM), and towards S. aureus threefold higher for the D-variant (IC 50 0.119 lM) than for the L-variant (IC 50 0.383 lM) (Fig. 1 c, d ). Both enantiomers were similarly active against E. coli (IC 50 = 0.63-1.25 lM), but showed slightly different activities against S. aureus (L-Cu1a: 0.63-1.25 lM; D-Cu1a: 0.32-0.63 lM). As to the insecticidal activity, the L-variant is about twofold less potent than D-Cu1a (LD 50 2.9 pmol/mg fly), with an LD 50 of 6.8 pmol/ mg fly. To explain these small differences in the activity of D-Cu1a towards bacteria and D. melanogaster we note Cu1a and L-Cu1a (0.04-100 lM) towards E. coli and S. aureus (*3.7 9 10 5 cfu/ml) was determined with the microtiter broth dilution assay. Cell growth was estimated by monitoring optical density at 630 nm and counting the resulting colony forming units after 18 h of incubation at 37°C that D-enantiomers are more resistant to degradation by proteases, which could be released into the media by bacteria and are present in flies after peptides injection due to tissue damage (Alvarez-Bravo et al. 1994; Bessalle et al. 1990; Vunnam et al. 1998 ). In the case of bacteria, both enantiomers are attracted by negatively charged phospholipids and lipopolysaccharides on the highly negatively charged outer membrane surfaces, resulting in a-helical conformation of the peptide and subsequent membrane disruption in a non-stereospecific manner. The cell surface of the bloodstream form of T. brucei is characterised by a dense monolayer of homodimers of surface glycoproteins (VSG) of approximately 15 nm thickness, which is net neutral at pH 8 (M.A. Ferguson, personal communication) (Mehlert et al. 1998) . The VSG layer acts as a macromolecular diffusion barrier only for molecules above 20 kDa (Mehlert et al. 2002) . Remarkably, the plasma membrane of T. brucei exhibits a very high cholesterol/phospholipid ratio of 1.54 (Voorheis et al. 1979) but it has also a high content of negatively charged phosphatidylserine and phosphatidylinositol. This could allow the enantiomers to electrostatically interact with the cell membrane, thus inducing severe damage as has been reported for insect defensin-derived synthetic peptides Patnaik et al. 1993) . In addition, a high content of lipid-bound sialic acid residues have been determined for bloodstream forms of T. brucei brucei (Carroll and McCrorie 1986) . These might also contribute to the electrostatic attraction of the peptides. Incubation of T. brucei with melittin, a cytolytic peptide isolated from honey bee venom in submicromolar concentrations, resulted in a calcium influx into the parasites without disrupting cell permeability, which only occurs at higher concentrations (Ruben et al. 1996) . Our results also support other reports concerning the trypanocidal activity of several antimicrobially acting peptides of diverse origin which act by disrupting membrane integrity (Boulanger et al. 2002; Kitani et al. 2009; Löfgren et al. 2008; McGwire et al. 2003; Yamage et al. 2009 ).
Due to the fact that no stereospecific effects of Cu1a-enantiomers on diverse membrane types could be demonstrated, the susceptibility of three further pathogenic eukaryotic parasites was investigated only with L-Cu1a. All three parasites, T. brucei rhodesiense (sleeping sickness), T. cruzi (Chagas' disease) and P. falciparum (malaria tropica) are sensitive to the peptide in the submicromolar range (Table 1) . Unexpectedly, rat skeletal myoblasts (L-6 cells), used as a control for cytotoxicity, exhibit an IC 50 of 0.342 lM; thus, these myoblasts are up to three times more sensitive than T. cruzi. The high susceptibility of L-6 cells towards L-Cu1a could possibly be explained by the presence of sialic acids on the cell surface (De Bank et al. 2003) , which could be responsible for membrane binding and lysis by The attraction of antimicrobial peptides due to negative charges of diverse bacterial membrane structures (lipopolysaccharides, phosphatidylglycerol, diphosphatidylglycerol) is beyond doubt, whereas the binding of cytolytic and antimicrobial peptides and subsequent cell membrane damage of erythrocytes are still poorly understood (Lohner 2001) . In the cytotoxicity standard test of antimicrobial peptides towards eukaryotic cells, erythrocytes are mainly used because they are abundant and easy to isolate. Human erythrocytes are characterised by an asymmetric distribution of phospholipids in its membrane. Negatively charged phosphatidylserine is located only in the inner leaflet, whereas the outer leaflet is composed of sphingomyelin, phosphatidylcholine, phosphatidylethanolamine and cholesterol (Verkleij et al. 1973 ). The overall negative charge of the erythrocytes is reduced to different carbohydrate structures containing sialic acids (Viitala and Järnefelt 1985) . Thus, a possible role for sialic acids as a factor which regulates the haemolytic activity of L-Cu1a could be tested by modifying human erythrocytes. Subsequent removal of sialic acid from the surface of human erythrocytes results in a *20% reduction of haemolysis caused by L-Cu1a, as demonstrated in Fig. 2 . In addition, reducing the overall negative charge of the human erythrocyte surface by application of increasing concentrations of trilysine and pentalysine before incubation with L-Cu1a, strongly reduces the haemolytic activity of cytolytic peptide (Fig. 3) . These combined observations point to the impact of the total surface charge of erythrocytes. In this experiment 29-h-old erythrocytes were used, which exhibit a higher susceptibility to L-Cu1a (2.5 lM L-Cu1a causes *90% haemolysis) than fresh erythrocytes (2.5 lM LCu1a causes *40% haemolysis). It seems that the negatively charged sialic acids on the cell surface of erythrocytes enable L-Cu1a to adopt an a-helical conformation, resulting in membrane binding by electrostatic attraction. In spite of lacking negatively charged phospholipids in the outer membrane, damage to the cell membrane occurs by insertion of the hydrophobic N-terminal part of L-Cu1a via a chirally independent mechanism (Kuhn-Nentwig et al. 2002a; Pukala et al. 2007a ).
Effects of L-Cu1a on different human cells
The cytolytic effect of L-Cu1a on different normal human blood cells, leukemic and tumour cells exhibits considerable differences (Table 2) . Considering lytic activity, granulocytes and lymphocytes are about 40-50 times more sensitive to L-Cu1a compared with human erythrocytes (EC 50 23 lM). The production of superoxide by the NADPH oxidase in PMA stimulated granulocytes is inhibited to 90% (99%) in the presence of 0.2 lM (0.5 lM) L-Cu1a. This inhibition occurs in about the same concentration range as reported for parabutoporin and opistoporin, cationic pore forming peptides isolated from the venom of South African scorpions (Willems et al. 2002 (Willems et al. , 2004 . The latter are also chemotactic for granulocytes but, in contrast to these results, no induction of a granulocyte chemotactic response could be observed with L-Cu1a in concentrations between 0.2 and 0.8 lM.
Furthermore, different human leukemic cell lines are 66-121 times more sensitive to L-Cu1a than human erythrocytes. Among the human tumour cells tested, HeLa are the most sensitive (EC 50 of 0.15 lM). Interestingly, HEK 293 tumour cells are about 2.9-fold more sensitive to the peptide than HEK 293-T cells. The latter cell line differs from HEK 293 in that it expresses, in rafts on the cell membrane, SV40 large T antigen. This protein contains many lysine and arginine residues at critical places (Henning and Lange-Mutschler 1983; Walser et al. 1989) . The reduction of the overall negative charge of the cells by the positively charged amino acids could lower the binding possibilities for L-Cu1a, resulting in less sensitive HEK 293-T cells. A comparable charge-dependent targeting of cationic dextran to different tumour cell lines is proposed in which the compound binds to sialic acid residues of different cancer cells, resulting in membrane disturbance and subsequently cell death (Márquez et al. 2004 ). In general, cancer cells are characterised by a higher content of phosphatidylserine, increased levels of sialic acids on the outer leaflet and high negative transmembrane potentials, which could allow interaction between the cells and antimicrobial/cytolytic peptides (Dennison et al. 2006) . Fig. 2 Partial sialic acid depletion of human erythrocytes reduces the cytolytic activity of L-Cu1a. Sialic acids were removed from fresh erythrocytes (20% hematocrit) by incubation with different concentrations of neuraminidase. Afterwards, erythrocytes (*1.6 9 10 7 cells/ml) were incubated with 5.4 lM L-Cu1a for 1 h at 37°C and haemolytic activity was measured at 541 nm Fig. 3 Preincubation of human erythrocytes with different concentrations of trilysine or pentalysine reduces the cytolytic activity of LCu1a. Here, 29-h-old erythrocytes (*1.7 9 10 8 cells/ml) were preincubated for 10 min at 25°C with different concentrations of tri-or penta-lysine. After incubation with 2.5 lM L-Cu1a for 1 h at 37°C haemolytic activity was measured as change in the absorbance at 541 nm Wullschleger et al. 2005 ). In the case of insects, muscle cells as well as nerves are encircled by basement membranes rich in acidic proteins such as glutactin and papilin; glia cells are enriched with negatively charged arthrosides (Kramerova et al. 2000; Olson et al. 1990; Sickmann et al. 1992) . Destroying these negatively charged membranes by diverse cupiennins could result in better access to their targets for the neurotoxins, e.g. different ion channels. With respect to the occurrence of different negatively charged cell structures in mammals (basement membranes, nervous tissues, internal surface of normal blood vessels, etc.), Cu1a as a ''cytolytic all-rounder'' is not suitable for the development of new antibiotics. Nevertheless, an understanding of the molecular basis for this broad cytolytic activity and unwanted cytotoxic activity of antimicrobial peptides on negatively charged cells and tissue types in mammals is very important in the development of new antibiotics.
